Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Hadassah Study Suggests Cancer Treatment for Kidney is Effective for Sarcoma Too

hMedicine

Dr. Daniela Katz

A recent study headed by Dr. Daniela Katz, Sarcoma Unit Coordinator at the Hadassah University Medical Center's Sharett Institute of Oncology, suggests that the biological therapy given to patients with kidney cancer is also effective for patients with sarcoma, a bone and soft tissue cancer.

The therapy is an oral medication called Pazopanib. When given to adults with advanced kidney cancer, the evidence indicates a statistically significant improvement in retarding tumor progression. Hadassah Hospital-Ein Kerem's Department of Oncology is now offering the treatment free of charge to sarcoma patients with advanced or metastatic disease.

Date: 2/15/2012


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America